Abstract
Background:
Otomycosis is a superficial infection of the ear caused by a spectrum of various fungal agents and its epidemiology depends on geographical region and climatic condition. The aim of this study was to investigate the causal agents and clinical manifestations of otomycosis at a tertiary referral center in Tehran, Iran.
Methods:
From Apr 2016 to Jan 2017 a set of 412 subjects with suspicion of external otitis were included. Clinical examination and specimen collection were performed by an otorhinolaryngologist. Subsequently, direct examination and culture were performed on specimens and isolated molds were identified morphologically. Yeast isolates were identified using CHROMagar Candida medium and PCR-RFLP of ribosomal DNA whenever needed. Data were analyzed using SPSS.
Results:
Otomycosis was confirmed in 117 cases (28.39%) including 64 (54.7%) males and 53 (45.3%) females. Patients were within the age range of 10–75 yr and the highest prevalence was found in the age group of 46–55 yr (30.77%). Pruritus (89.74%) and auditory manipulation and trauma (83.76%) were the predominant symptom and predisposing factor, respectively. Among 133 isolates from 117 patients, Aspergillus niger (n=50, 37.59%) was the most common etiologic agent and Candida glabrata (n=25, 18.8%) was the predominantly isolated yeast. Furthermore, 16 cases of mixed infection were identified and coinfection due to A. niger and C. glabrata (seven cases) was the predominant pattern.
Conclusion:
Our results revealed the high prevalence of C. glabrata and mixed infections in otomycosis patients. Therefore, mycological examinations should be considered for proper treatment.
Keywords: Otitis externa, Aspergillus niger, Candida glabrata, Iran
Introduction
Otomycosis is a superficial fungal infection of the ear involving the external auditory canal, auricle and even tympanic membrane (1, 2). The causative agents include a wide spectrum of saprophytes (hyaline and dematiaceous), yeasts and rarely dermatophytes (3–5). Although more than 50 species of fungi, including Penicillium spp., Fusarium spp., Mucoracae, Scopulariopsis spp., Alternaria spp., Malassezia spp., Candida spp. and dermatophytes have been reported as pathogenic agents of otomycosis (6–8). However, most studies reported Aspergillus niger and Candida albicans as the most common causes of otomycosis (7, 9).
The prevalence of otomycosis among all cases of otitis externa is reported to be more than 10% (8). Although both genders and all age groups are affected by otomycosis, this condition is more common in the Middle Ages (10, 11).
Otalgia, itching, hearing loss, ear fullness, and tinnitus are the most common clinical manifestations of fungal otitis (12–14). The prevalence of otomycosis and its fungal agents varies in different geographical areas (3) and can be influenced by several predisposing factors such as hot and humid climate, swimming, traumatic injuries or manipulation of the ear canal and also bacterial infections (15, 16).
Azoles, such as clotrimazole, fluconazole, and miconazole are more effective than other anti-fungal drugs in treatment of otomycosis and apparently, they have no ototoxic properties (17). Meanwhile, proper aural hygiene and cleaning the discharges and debris in the ear seems to be effective in topical treatments (17). Furthermore, regarding the recurrence of disease due to insufficient and inadequate treatment, proper identification of the pathogenic agents could be helpful in finding the accurate therapeutic strategies (17). Accordingly, the present study carried out to determine the prevalence of otomycosis and its etiological agents in patients with suspected otitis externa, and to determine the predisposing factors and clinical manifestations of patients in a tertiary referral center in Tehran, Iran.
Material and Methods
Patients
This descriptive cross-sectional study was conducted from Apr 2016 to Jan 2017 on patients referred to the AmirAlam Hospital as a tertiary referral center affiliated to Tehran University of Medical Sciences, Tehran, Iran. All subjects with clinical symptoms indicative of otitis such as otalgia, itching, discharge met the inclusion criteria for enrollment in this study.
All patients read, understood and signed the informed consent statement and the present study was approved by the Ethics Committee of Tehran University of Medical Sciences (Ethics code: IR.TUMS.SPH.REC.1395.1793).
Demographic data, clinical history and manifestations, and underlying factors of all individuals were recorded through questionnaires and clinical examinations. Subsequently, specimen collection was performed by an otolaryngologist using sterile swabs. The specimens immediately were transferred to the Medical Mycology Laboratory, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran, for further investigations.
Direct examination and culture
Direct microscopic examination was performed on all specimens using 10% KOH. Furthermore, all samples were cultured on the sabouraud dextrose agar (SDA, Merck, Germany) and SDA supplemented with chloramphenicol (QUELAB, UK) and incubated at 30 °C for 20 d. All culture plates were checked daily in the first week and afterward at least three times a week. Mold isolates were identified based on the microscopic and macroscopic characteristics of colony. In order to identify Candida species, CHROMagar Candida medium (CHROMagar, France) was utilized.
Molecular identification
Candida isolates with ambiguous colony colors on CHROMagar Candida medium were identified using PCR-RFLP of the internal transcribed spacer regions of rDNA. In this regard, primers ITS1 (5′-TCC GTA GGT GAA CCT GCG G-3′) and ITS4 (5′ –TCC TCC GCT TAT TGA TAT GC-3′) and restriction enzyme MspI were used (18).
Statistical analysis
Data were analyzed using SPSS software ver. 15 (Chicago, IL, USA). In order to determine the association between different predisposing factors with the occurrence of otomycosis, Chi-square test was performed. P<0.05 was considered statistically significant.
Results
Totally 412 patients with a suspicion of otitis externa in the age range of 9 to 75 yr were enrolled. Of them, 117 (28.39%) patients including 64 (54.7%) males and 53 (45.3%) females were confirmed for otomycosis. The patients were within the age range of 10–75 yr and the highest prevalence of otomycosis was found in the age group of 46–55 yr. Table 1 represents the distribution of patients based on their gender among different age groups. Among these cases, pruritus was the most common symptom (89.74%) and scaling had the lowest prevalence (14.53%) (Fig. 1).
Table 1:
Patients(N=117) | Gender | Age ranges (yr) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
≤15 | 16–25 | 26–35 | 36–45 | 46–55 | 56–65 | 66–75 | ||||
Positive cases (n) (%) | Male | 1 (0.85) | 6 (5.13) | 15 (12.82) | 11 (9.4) | 19 (16.24) | 10 (8.55) | 2 (1.71) | ||
Female | 0 | 3 (2.56) | 12 (10.25) | 10 (8.55) | 17 (14.53) | 7 (5.98) | 4 (3.41) | |||
Total (n) (%) | - | 1 (0.85) | 9 (7.69) | 27 (23.07) | 21 (17.95) | 36 (30.77) | 17 (14.53) | 6 (5.12) |
Trauma/manipulation of the ear canal, history of bacterial infection and swimming were found in 83.76%, 33.33%, and 30.77% of patients, respectively. These predisposing factors were significantly associated with the occurrence of otomycosis (P<0.001).
Based on the results of culture and molecular analysis (PCR-RFLP), A. niger (37.59%) was the dominant etiology of otomycosis in our study. Moreover, C. glabrata was the most frequent Candida species (18.8%). The spectrum of fungal species and their frequency are presented in Table 2. Furthermore, mixed fungal otitis was observed in 16 of 117 patients (13.67%). The majority of mixed cases were due to A. niger and C. glabrata (7 patients) followed by A. niger and A. flavus (4 patients) (Table 3).
Table 2:
Fungi | Frequency | Percent |
---|---|---|
Aspergillus niger | 50 | 37.59 |
Aspergillus flavus | 36 | 27.06 |
Candida glabrata | 25 | 18.79 |
Candida albicans | 7 | 5.26 |
Candida tropicalis | 5 | 3.76 |
Penicillium spp. | 4 | 3 |
Candida parapsilosis | 2 | 1.5 |
Malassezia spp. | 2 | 1.5 |
Mucor spp. | 1 | 0.75 |
Rhizopus spp. | 1 | 0.75 |
Total | 133a | 100 |
Mixed infections were observed in 16 patients.
Table 3:
Fungal agents | Number of patients |
---|---|
A. niger + C. glabrata | 7 |
A. niger + A. flavus | 4 |
A. flavus + C. glabrata | 2 |
A. niger + C. parapsilosis | 1 |
A. flavus + C. albicans | 1 |
A. flavus + C. tropicalis | 1 |
Total | 16 |
Discussion
We evaluated the prevalence of otomycosis among patients with a suspicion of infectious otitis in AmirAlam hospital as a tertiary referral medical center for ear, nose and throat disorders in Tehran, Iran. The prevalence of otomycosis was 28.39% (117 of 412). This finding is not in agreement with findings which reported the prevalence of otomycosis as 80%, 92%, 69%, and 78%, respectively (16, 19–21). However, some investigations reported the prevalence as 43%, 33.25%, 30.4%, and 19%, respectively, which are similar to our results (2, 22–24). These variations in results are probably due to different inclusion criteria. While, in some studies, only the individuals with a strong clinical suspicion of otomycosis are included, in our study all patients with a suspicion of infectious otitis were enrolled.
In this study, males were slightly more affected than females (64:53) in all age groups except the range of 66–75 yr. However, this difference was not statistically significant. Higher rate of male involvement is reported by some authors (20, 25), while, others reported female as the most affected gender (2, 23, 26). Moreover, the highest prevalence was recorded in the age group of 46–55 yr (30.77%) followed by 26–35 yr (23.07%). The highest prevalence of otomycosis is reported in 20–39 yr (23), 27–48 yr (22), 21–40 yr (20), 30–50 yr (26), and 31–40 yr (16) by some authors. These variations could be mainly due to the different patterns of age grouping or differences in geographical regions and climatic conditions.
Pruritus was the most common symptom (105, 89.74%) among 117 otomycosis patients. In agreement with our results, this complaint is reported as the predominant symptom in other studies (16, 19, 20, 25, 27). However, others reported ear fullness (28) and otalgia and otorrhea (15) as the main clinical symptom. Considering the divergent results in different studies and similarities between symptoms of bacterial and fungal otitis, the clinical symptoms are not specific for otomycosis. Therefore, clinical and laboratory findings should be used simultaneously for making the final decision on drug administration.
Auditory trauma/manipulation was the main predisposing factor observed in 83.76% of patients followed by a history of bacterial infection (33.33%), and swimming (30.77%). Similarly, injuries to the ear canal was reported as the most frequent predisposing factor of otomycosis (25, 27). This could be due to the defect in the skin caused by the injuries. Skin acts as the primary defense against various pathogens; therefore, lack of its normal structure facilitates the colonization and infection by different microorganisms including fungi.
During the laboratory analysis of specimens, a set of 133 fungal isolates including 92 (69.17%) molds and 41 (30.83%) yeasts were recovered from 117 patients. A. niger (n=50, 37.59%) was the most common isolated species followed by A. flavus (n=36, 27.06%). Among the yeast isolates which totally belonged to the genus Candida, C. glabrata (n= 25, 18.79%) was the most common species. In accordance with our findings, A. niger was reported as the most common species in some studies (20, 23, 25–27, 29). However, in other studies, A. flavus was reported as the leading fungal etiology of otomycosis (16, 19). In addition, C. parapsilosis was the most common species (24). Since in the most of studies, A. niger and A. flavus were specified as the most prevalent fungal etiology of otomycosis, uncommon species should not be ignored. In our study, C. glabrata was recovered from 25 (18.76%) patients. This is not a common finding in literature. Some of non-albicans Candida species are intrinsically resistant to azole antifungal drugs. Therefore, they could cause treatment failure and should be taken into account.
Mixed fungal otitis was identified in 16 patients in our study. Coinfection due to A. niger and C. glabrata was the most frequent pattern (7 cases), followed by A. niger and A. flavus (4 cases). In agreement with our results, two cases of mixed otomycosis caused by Aspergillus species and C. albicans were reported (28). Furthermore, five cases of mold and yeast coinfection were found among 88 otomycosis patients which were due to A. flavus and C. albicans (2 cases), A. flavus and C. parapsilosis (1 case), A. flavus and C. guilliermondii (1 case) and A. flavus and C. famata (1 case) (19). Regarding the endogenous nature of Candida species, the control and prevention of infections caused by them is completely different from those due to exogenous fungi such as Aspergillus species. This issue should be highlighted in treatment, control, and prevention of otomycosis. Therefore, treatment failure and recurrence of disease is not an unexpected result in the cases of otomycosis treated based on clinical symptoms and without the laboratory findings.
Conclusion
Otomycosis was diagnosed in 117 of 412 patients with almost an equal distribution among male and female subjects. A. niger was the predominant species similar to the majority of other reports. High prevalence of C. glabrata and also 16 cases of mixed fungal otitis were identified. Regarding inter/intra species and genus differences in susceptibility patterns of fungi, it is preferred to perform laboratory analysis prior to empirical treatment of patients.
Ethical considerations
Ethical issues (Including plagiarism, informed consent, misconduct, data fabrication and/or falsification, double publication and/or submission, redundancy, etc.) have been completely observed by the authors.
Acknowledgements
This study was financially supported by Tehran University of Medical Sciences, Tehran, Iran (grant No. 33975).
Footnotes
Conflict of interest
The authors declare that there is no conflict of interests.
References
- 1.Kaieda S. (2008). Fungal infection in the otorinolaryngologic area. Nihon Rinsho, 66 (12): 2290–3 [in Japanese]. [PubMed] [Google Scholar]
- 2.Cheraghsahar S, Kazemi S, Birjandi M, et al. (2017). Otomycosis in Western Iran: Clinical and Mycological Aspects. Arch Clin Infect Dis, 12 (2): e57287. [Google Scholar]
- 3.García-Agudo L, Aznar-Marín P, Galán-Sánchez F, et al. (2011). Otomycosis due to filamentous fungi. Mycopathologia, 172 (4): 307–10. [DOI] [PubMed] [Google Scholar]
- 4.Latha R, Sasikala R, Muruganandam N. (2010). Chronic otomycosis due to Malassezia spp. J Glob Infect Dis, 2 (2): 189–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Dorko E, Jenča A, Orenčák M, et al. (2004). Otomycoses of candidal origin in eastern Slovakia. Folia Microbiol, 49 (5): 601–4. [DOI] [PubMed] [Google Scholar]
- 6.Ozcan M, Ozcan MK, Karaarslan A, et al. (2003). Concomitant otomycosis and dermatomycoses: a clinical and microbiological study. Eur Arch Otorhinolaryngol, 260 (1): 24–7. [DOI] [PubMed] [Google Scholar]
- 7.Vennewald I, Klemm E. (2010). Otomycosis: diagnosis and treatment. Clin Dermatol, 28 (2): 202–11. [DOI] [PubMed] [Google Scholar]
- 8.Gharaghani M, Seifi Z, Mahmoudabadi AZ. (2015). Otomycosis in Iran: A Review. Mycopathologia, 179 (5–6): 415–24. [DOI] [PubMed] [Google Scholar]
- 9.Martin TJ, Kerschner JE, Flanary VA. (2005). Fungal causes of otitis externa and tympanostomy tube otorrhea. Int J Pediatr Otorhinolaryngol, 69 (11): 1503–8. [DOI] [PubMed] [Google Scholar]
- 10.Fayemiwo S, Ogunleye V, Adeosun A, et al. (2010). Prevalence of otomycosis in Ibadan: a review of laboratory reports. Afr J Med Med Sci, 39: 219–22. [PubMed] [Google Scholar]
- 11.Nwabuisi C, Ologe F. (2001). The fungal profile of otomycosis patients in Ilorin, Nigeria. Niger J Med, 10 (3): 124–6. [PubMed] [Google Scholar]
- 12.Pontes ZBVdS, Silva ADF, Lima EdO, et al. (2009). Otomycosis: a retrospective study. Braz J Otorhinolaryngol, 75 (3): 367–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kaur R, Mittal N, Kakkar M, et al. (2000). Otomycosis: a clinicomycologic study. Ear Nose Throat J, 79 (8): 606–9. [PubMed] [Google Scholar]
- 14.Fasunla J, Ibekwe T, Onakoya P. (2008). Otomycosis in western Nigeria. Mycoses, 51 (1): 67–70. [DOI] [PubMed] [Google Scholar]
- 15.Ho T, Vrabec JT, Yoo D, et al. (2006). Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg, 135 (5): 787–91. [DOI] [PubMed] [Google Scholar]
- 16.Barati B, Okhovvat S, Goljanian A, et al. (2011). Otomycosis in central Iran: a clinical and mycological study. Iran Red Crescent Med J, 13 (12): 873–6. [PMC free article] [PubMed] [Google Scholar]
- 17.Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review (2008). Int J Pediatr Otorhinolaryngol, 72 (4): 453–9. [DOI] [PubMed] [Google Scholar]
- 18.Mirhendi H, Makimura K, Khoramizadeh M, et al. (2006). A one-enzyme PCR-RFLP assay for identification of six medically important Candida species. Nihon Ishinkin Gakkai Zasshi. 47 (3): 225–9. [DOI] [PubMed] [Google Scholar]
- 19.Adoubryn KD, N’Gattia VK, Kouadio-Yapo GC, et al. (2014). [Epidemiology of otomycoses at the University Hospital of Yopougon (Abidjan-Ivory Coast)]. J Mycol Med, 24 (2): e9–15. [DOI] [PubMed] [Google Scholar]
- 20.Kazemi A, Majidinia M, Jaafari A, et al. (2015). Etiologic Agents of Otomycosis in the North-Western Area of Iran. Jundishapur J Microbiol, 8 (9): e21776. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Aneja K, Sharma C, Joshi R. (2010). Fungal infection of the ear: a common problem in the north eastern part of Haryana. Int J Pediatr Otorhinolaryngol, 74 (6): 604–7. [DOI] [PubMed] [Google Scholar]
- 22.Nemati S, Hassanzadeh R, Jahromi SK, et al. (2014). Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents. Eur Arch Otorhinolaryngol. 2014; 271 (5): 953–7. [DOI] [PubMed] [Google Scholar]
- 23.Saki N, Rafiei A, Nikakhlagh S, et al. (2013). Prevalence of otomycosis in Khouzestan Province, south-west Iran. J Laryngol Otol, 127 (01): 25–7. [DOI] [PubMed] [Google Scholar]
- 24.Kurnatowski P, Filipiak A. (2001). Otomycosis: prevalence, clinical symptoms, therapeutic procedure. Mycoses, 44 (11–12): 472–9. [DOI] [PubMed] [Google Scholar]
- 25.Abdelazeem M, Gamea A, Mubarak H, et al. (2015). Epidemiology, causative agents, and risk factors affecting humanotomycosis infections. Turk J Med Sci, 45 (4): 820–6. [DOI] [PubMed] [Google Scholar]
- 26.Nowrozi H, Arabi FD, Mehraban HG, et al. (2014). Mycological and clinical study of otomycosis in Tehran, Iran. Bull Env Pharmacol Life Sci, 3 (2): 29–31. [Google Scholar]
- 27.Jia X, Liang Q, Chi F, et al. (2012). Otomycosis in Shanghai: aetiology, clinical features and therapy. Mycoses, 55 (5): 404–9. [DOI] [PubMed] [Google Scholar]
- 28.Pradhan B, Tuladhar NR, Amatya RM. (2003). Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Ann Otol Rhinol Laryngol, 112 (4): 384–7. [DOI] [PubMed] [Google Scholar]
- 29.Kiakojuri K, Rajabnia R, Jalili B, et al. (2015). Otomycosis in Adolescent Patients Referred to the Therapeutic Centers in Babol City, Iran. Jundishapur J Microbiol, 8 (5): e17138. [DOI] [PMC free article] [PubMed] [Google Scholar]